NMBR and Alzheimer disease: Although in vivo validation in AD model is still lacking, the pivotal role of NMB/NMBR signaling in neuroinflammation and synaptic plasticity positions the development of highly selective NMB antagonists as a promising new therapeutic strategy for AD.